Legal action has been taken by the European Union against AstraZeneca over its vaccine delivery failures to the EU.
The action, which was launched on behalf of the 27 member states, started last Friday on the basis of breaches of the advanced purchase agreement.
The predominant basis for the legal action is in regards to AstraZeneca’s failure to deliver its promised 100 million doses to EU in the first quarter of the year but only delivered 29.4 million.
Production issues led to the significant shortfall to which AstraZeneca defended by stating that the contract between itself and the EU said it would do its best efforts to deliver the supplies on time.
However, the EU stated that the contract also says that AstraZeneca’s British factories should only be used to supply vaccines to the EU and that no other contract, such as the Australian contract, should interfere with this.